Actors and Network database
The evolving field of gene and cell therapy is supported by a large community of academic, clinical, translational, regulatory and patient organisations. The Actors and Networks database maps these stakeholders in Europe and beyond, their activities, and resources they have produced.
EuroGCT has developed and compiled this database for those interested in identifying the actors involved at each stage of the pathways bringing gene and cell therapies from lab to clinic. Coming from an academic perspective, our focus is to map information that has not been mapped elsewhere. This includes documenting the various types of interconnected regulators, patient groups actively involved along the pathways, and non-profit organisations devoted to therapy development. In its first iteration, this database does not yet include commercial partners and service providers.
The European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT)
Additional information
EuroGCT brings together 47 partner organisations and institutions across Europe with a goal of providing reliable and accessible information about the use of cells and genetic material to treat disease.
The Fraunhofer Institute for Biomedical Engineering (Fraunhofer IBMT)
Additional information
Fraunhofer IBMT has been working in the field of stem cell research and hosting extensive cell line stocks in industrial and clinically structured biobanks for low temperature storage of valuable samples (fluids, cells, tissue fragments).
The Roslin Institute, The University of Edinburgh (The Roslin Institute)
Additional information
The Roslin Institute offers unique expertise and infrastructure to conduct pioneering animal biosciences, aiming to achieve sustainable agriculture, control diseases and enhance health.